[1]
Świerczyński M. and Więckowski Z. 2019. Biosimilars and the Patent Law. Medicine, Law & Society. 12, 2 (Oct. 2019), 21-38. DOI:https://doi.org/10.18690/mls.12.2.21-38.2019.